Profile data is unavailable for this security.
About the company
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.
- Revenue in USD (TTM)31.90bn
- Net income in USD3.60bn
- LocationAbbott Laboratories100 Abbott Park RdABBOTT PARK 60064-3500United StatesUSA
- Phone+1 (224) 667-6100
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|ABT:NYQ since |
|GLP Systems GmbH||Deal completed||27 Jun 2019||27 Jun 2019Deal completed||-4.54%||147.78m|